Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
about
Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of interventionDorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports.In vivo imaging reveals novel aspects of retinal disease progression in Rs1h(-/Y) mice but no therapeutic effect of carbonic anhydrase inhibition.Macular retinal detachment associated with intrachoroidal cavitation in myopic patients.A case of paclitaxel-induced maculopathy treated with methazolamide.Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.Clinical review: Update on treatment of inflammatory macular edema.Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.Management of Cystoid Macular Edema in Retinitis Pigmentosa.Topical dorzolamide treatment of macular cysts in the enhanced S-cone syndrome patient.Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide.Topical dorzolamide therapy for taxane-related macular oedemaEfficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome.Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa.The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.Topical carbonic anhydrase inhibitors in macular edema associated with Alström syndrome.
P2860
Q28076321-C6B64F09-C0F0-40E6-85B4-148063DD5650Q33734786-8842FB14-487C-46E0-9260-176995063A31Q34294086-BD01CFCE-2540-41CC-A40E-FD1FA8DBE1F9Q35390871-F9BD4B67-F50C-4118-A563-6B63D605FA83Q36297617-D99B8586-FE25-4B23-BC18-2E01CC5D1544Q36967025-F7C84B82-5030-4DD4-99DC-5DE7A83353D3Q37804876-ADAED02B-EE43-4CF9-858A-BD5FB4D26D02Q37963356-01CDA246-09DE-44E2-B9E3-78DC8E53ED00Q38982477-AC3548E5-CEC1-4F8D-9E0C-75010583C372Q41072032-6DED3A54-AD25-4B25-842D-25AA43F075B4Q41953086-5CAB9774-5DFA-4CB7-B7AE-3662111FC76BQ42734068-F2842A06-06DB-4D7D-8F26-A1513FED1A5AQ42907056-3B50BDAA-C51E-42C4-8780-53EA159C08B4Q44536567-FCC7A29C-8AC6-4B55-8C30-C64A769B78B2Q46247271-F3FE2EDB-B575-43DE-9E0A-0B622AD8D42EQ47959986-9B96E307-84F8-421A-A2C2-2AF60EC8AED0
P2860
Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Continued use of dorzolamide f ...... nts with retinitis pigmentosa.
@en
Continued use of dorzolamide f ...... nts with retinitis pigmentosa.
@nl
type
label
Continued use of dorzolamide f ...... nts with retinitis pigmentosa.
@en
Continued use of dorzolamide f ...... nts with retinitis pigmentosa.
@nl
prefLabel
Continued use of dorzolamide f ...... nts with retinitis pigmentosa.
@en
Continued use of dorzolamide f ...... nts with retinitis pigmentosa.
@nl
P2860
P356
P1476
Continued use of dorzolamide f ...... nts with retinitis pigmentosa.
@en
P2093
Gerald A Fishman
Marsha A Apushkin
P2860
P304
P356
10.1136/BJO.2006.107466
P407
P577
2007-01-10T00:00:00Z